Ferreira João, Fernandes Diogo, Marques-Alves Patrícia, Saleiro Carolina, Elvas Luís, Gonçalves Lino
Serviço de Cardiologia, Centro Hospitalar e Universitário de Coimbra, Coimbra, Portugal.
Serviço de Cardiologia, Centro Hospitalar e Universitário de Coimbra, Coimbra, Portugal; Faculdade de Medicina, Universidade de Coimbra, Coimbra, Portugal.
Rev Port Cardiol. 2025 Jun;44(6):377-385. doi: 10.1016/j.repc.2024.12.006. Epub 2025 May 6.
Left bundle branch area pacing (LBBAP) is a technique suitable for treating both symptomatic bradycardia and cardiac resynchronization therapy (CRT). Our study aims to describe the first experience of LBBAP in a high-volume cardiac implantable electronic device (CIED) center.
This prospective single-center observational registry included consecutive patients who underwent pacemaker implantation with LBBAP technique for sinus node disease, bradycardia and CRT indications between January 2023 and January 2024. Procedural data, outcomes, and lead parameters were recorded at hospital discharge, at one and six months of follow-up.
A total of 164 consecutive patients undergoing LBBAP implantation were included, of whom 142 had a stylet-driven lead. LLBAP was achieved in 94.5% patients. Average QRS duration was 139.8±33.4 ms. Complete atrioventricular block was the most common indication (42.7%). CRT was performed in 24 (14.5%) patients. Mean procedural duration was 82.7±24.4 min and mean fluoroscopy time was 13.7±7.1 min. Average LVAT was 78.8±8.7 ms and paced QRS width 114.8±14.4 ms. Median acute R-wave amplitude was 14.0 mV, pacing threshold was 0.5 V and impedance 526 Ω. No relevant per-operative complications occurred. After one month of follow-up, median pacing threshold had significantly increased to 0.75 V (p<0.001) while R-wave amplitude and impedance remained unchanged (p=0.242 and p=0.101 respectively). During follow-up, no changes occurred in the evaluated parameters. Loss of left bundle branch capture occurred in five patients and macro-dislodgement in 2.
LBBAP is a feasible pacing technique which reduces QRS duration and improves LV synchrony and can be adopted at most centers, with favorable success rates and safety profile.
左束支区域起搏(LBBAP)是一种适用于治疗症状性心动过缓和心脏再同步治疗(CRT)的技术。我们的研究旨在描述在一个大容量心脏植入式电子设备(CIED)中心开展LBBAP的首次经验。
这项前瞻性单中心观察性登记研究纳入了2023年1月至2024年1月期间因窦房结疾病、心动过缓和CRT适应证而采用LBBAP技术进行起搏器植入的连续患者。在出院时、随访1个月和6个月时记录手术数据、结果和导线参数。
共纳入164例连续接受LBBAP植入的患者,其中142例使用了鞘管驱动导线。94.5%的患者成功实现左束支区域起搏。平均QRS时限为139.8±33.4毫秒。完全性房室传导阻滞是最常见的适应证(42.7%)。24例(14.5%)患者接受了CRT治疗。平均手术时间为82.7±24.4分钟,平均透视时间为13.7±7.1分钟。平均左心室激活时间(LVAT)为78.8±8.7毫秒,起搏QRS宽度为114.8±14.4毫秒。急性R波振幅中位数为14.0毫伏,起搏阈值为0.5伏,阻抗为526欧姆。术中未发生相关并发症。随访1个月后,起搏阈值中位数显著增加至0.75伏(p<0.001),而R波振幅和阻抗保持不变(分别为p=0.242和p=0.101)。随访期间,评估参数未发生变化。5例患者发生左束支捕捉丧失,2例发生导线大幅移位。
LBBAP是一种可行的起搏技术,可缩短QRS时限,改善左心室同步性,大多数中心均可采用,成功率高且安全性良好。